| Name | Title | Contact Details |
|---|---|---|
Eugene Staiger |
VP Sales & Director of Marketing | Profile |
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Precision AQ is a global life science commercialization vendor that specializes in Health Economics and Outcomes Research (HEOR), pricing, and market access consulting for pharmaceutical and biotech companies. Headquartered in New York City, the company operates with a strong emphasis on remote work. Precision AQ is dedicated to transforming patient lives by improving access to life-changing therapies through innovative strategies and data-driven approaches. The company offers a wide range of services to support clients throughout the healthcare journey. These include research, strategy, and product development, as well as marketing, branding, and public relations. Precision AQ also focuses on generating evidence for HEOR, optimizing payer access, and facilitating investor relations. Their expertise helps clients navigate the complexities of the market and enhance their presence among healthcare professionals and patients.
Hancock and Moore Fine Furniture
PMC Associates is a family-owned and operated technology integrator, specializing in Two-Way Radio Systems and Subscribers, as well as other Mission-Critical Communications equipment. Founded in 1988, and located in Hazlet, New Jersey, PMC serves the NYC Metropolitan area, as well as upstate NY, NJ, PA, DE, MD, DC and VA.